IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells

Kidney International

Volumn 67, Issue 2, 2005, Pages 504-513

  Novak, Jan ^b   Tomana, Milan ^c   Matousovic, Karel ^a   Brown, Rhubell ^c   Hall, Stacy ^c   Novak, Lea ^c   Julian, Bruce A ^c   Wyatt, Robert J ^c   Mestecky, Jiri ^c  

^a CHARLES UNIVERSITY   (Czech Republic)

^b University of Alabama at Birmingham   (United States)

^c NONE

Author keywords

Autoimmunity; Glomerulonephritis; Glycosylation; Immunoglobulin A (IgA); O linked glycans

Indexed keywords

ANTIBODY; GALACTOSE; IMMUNOGLOBULIN A1;

ADULT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FRACTIONATION; GEL PERMEATION CHROMATOGRAPHY; GLYCOSYLATION; HEMATURIA; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MESANGIUM CELL; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 12344284903     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.67107.x     Document Type: Article

References (59)

1. EMANCIPATOR SN: IgA nephropathy and Henoch-Schönlein syndrome, in Heptinstall's Pathology of the Kidney, edited by Jennette JC, Olson JL, Schwartz MM, et al, Philadelphia, Lippincott-Raven Publishers, 1998, pp 479-539
2. BERGER J, HINGLAIS N: Les depots intercapillaires d'IgA-IgG (intercapillary deposits of IgA-IgG). J Urol Nephrol 74:694-695, 1968
3. CONLEY ME, COOPER MD, MICHAEL AF: Selective deposition of immunoglobulin A1 in immunoglobulin A nephropathy, anaphylactoid purpura nephritis, and systemic lupus erythematosus. J Clin Invest 66:1432-1436, 1980
4. JULIAN BA, TOMANA M, NOVAK J, et al: Progress in the pathogenesis of IgA nephropathy. Adv Nephrol 29:53-72, 1999
5. NOVAK J, JULIAN BA, TOMANA M, et al: Progress in molecular and genetic studies of IgA nephropathy. J Clin Immunol 21:310-327, 2001
6. COPPO R, AMORE A, CIRINA P, et al: IgA serology in recurrent and non-recurrent IgA nephropathy after renal transplantation. Nephrol Dial Transplant 10:2310-2315, 1995
7. JULIAN BA, SAID M, BARKER CV: Allograft loss in IgA nephropathy. J Am Soc Nephrol 9:91A, 1998
8. ODUM J, PEH CA, CLARKSON AR, et al: Recurrent mesangial IgA nephritis following renal transplantation. Nephrol Dial Transplant 9:309-312, 1994
9. SILVA FG, CHANDER P, PIRANI CL, et al: Disappearance of glomerular mesangial IgA deposits after renal allograft transplantation. Transplantation 33:241-246, 1982
10. CZERKINSKY C, KOOPMAN WJ, JACKSON S, et al: Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies. J Clin Invest 77:1931-1938, 1986
11. COPPO R, BASOLO B, PICCOLI G, et al: IgA1 and IgA2 immune complexes in primary IgA nephropathy and Henoch-Schönlein nephritis. Clin Exp Immunol 57:583-590, 1984
12. TOMANA M, MATOUSOVIC K, JULIAN BA, et al: Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int 52:509-516, 1997
13. COPPO R, BASOLO B, MARTINA G, et al: Circulating immune complexes containing IgA, IgG and IgM in patients with primary IgA nephropathy and with Henoch-Schönlein nephritis. Correlation with clinical and histologic signs of activity. Clin Nephrol 18:230-239, 1982
14. GONZALES-CABRERO J, EGIDO J, MAMPASO F, et al: Characterization of circulating idiotypes containing immune complexes and their presence in the glomerular mesangium in patients with IgA nephropathy. Clin Exp Immunol 76:204-209, 1989
15. VAN DEN WALL BAKE AWL, BRUIJN JA, ACCAVITTI MA, et al: Shared idiotypes in mesangial deposits in IgA nephropathy are not disease-specific. Kidney Int 44:65-74, 1993
16. ANDRE PM, POGAMP P, CHEVET P: Impairment of jacalin binding to serum IgA in IgA nephropathy. J Clin Lab Anal 4:115-119, 1990
17. MESTECKY J, TOMANA M, CROWLEY-NOWICK PA, et al: Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy. Contrib Nephrol 104:172-182, 1993
18. ALLEN AC, HARPER SJ, FEEHALLY J: Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy. Clin Exp Immunol 100:470-474, 1995
19. HIKI Y, HORII A, IWASE H, et al: O-linked oligosaccharide on IgA1 hinge region in IgA nephropathy. Fundamental study for precise structure and possible role. Contrib Nephrol 111:73-84, 1995
20. TOMANA M, NOVAK J, JULIAN BA, et al: Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest 104:73-81, 1999
21. ALLEN AC, BAILEY EM, BRENCHLEY PEC, et al: Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: Observations in three patients. Kidney Int 60:969-973, 2001
22. HIKI Y, ODANI H, TAKAHASHI M, et al: Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int 59:1077-1085, 2001
23. ALLEN AC, WILLIS FR, BEATTIE TJ, et al: Abnormal IgA glycosylation in Henoch-Schönlein purpura restricted to patients with clinical nephritis. Nephrol Dial Transplant 13:930-934, 1998
24. LEVINSKY RJ, BARRATT TM: IgA immune complexes in Henoch-Schönlein purpura. Lancet 2:1100-1103, 1979
25. ALLEN AC, TOPHAM PS, HARPER SJ, et al: Leucocyte β1,3 galactosyltransferase activity in IgA nephropathy. Nephrol Dial Transplant 12:701-706, 1997
26. ALLEN A, FEEHALLY J: IgA glycosylation in IgA nephropathy. Adv Exp Med Biol 435:175-183, 1998
27. ALLEN AC, BAILEY EM, BUCK KS, et al: O-glycosylation of mesangial IgA1 in IgA nephropathy. J Am Soc Nephrol 10:506A, 1999
28. COPPO R, EMANCIPATOR S: Pathogenesis of IgA nephropathy: Established observations, new insights and perspectives in treatment. J Nephrol 7:5-15, 1994
29. COUSER WG: Glomerulonephritis. Lancet 353:1509-1515, 1999
30. HIKI Y, KOKUBO T, IWASE H,et al: Underglycosylation of IgA1 hinge plays a certain role for its glomerular deposition in IgA nephropathy. J Am Soc Nephrol 10:760-769, 1999
31. ALLEN AC: Abnormal glycosylation of IgA: Is it related to the pathogenesis of IgA nephropathy? Nephrol Dial Transplant 10:1121-1124, 1995
32. BAHARAKI D, DUEYMES M, PERRICHOT R, et al: Aberrant glycosylation of IgA from patients with IgA nephropathy. Glycoconj J 13:505-511, 1996
33. LEUNG JCK, POON PYK, LAI KN: Increased sialylation of polymeric immunoglobulin A1: Mechanism of selective glomerular deposition in immunoglobulin A nephropathy? J Lab Clin Med 133:152-160. 1999
34. FLOEGE J, FEEHALLY J: IgA nephropathy: Recent developments. J Am Soc Nephrol 11:2395-2403, 2000
35. MESTECKY J, TOMANA M, MATOUSOVIC K, et al: Heterogeneity of carbohydrate moieties of IgA1 molecules from IgA nephropathy patients and normal individuals. Nephrology 3:85-89, 1997
36. MESTECKY J, NOVAK J, JULIAN BA, et al: Pathogenic potential of galactose-deficient IgA1 in IgA nephropathy. Nephrology 7:S92-S99, 2002
37. KOKUBO T, HIKI Y, IWASE H, et al: Exposed peptide core of IgA1 hinge region in IgA nephropathy. Nephrol Dial Transplant 14:81-85, 1999
38. KOKUBO T, HASHIZUME K, IWASE H, et al: Humoral immunity against the proline-rich peptide epitope of the IgA1 hinge region in IgA nephropathy. Nephrol Dial Transplant 15:28-33, 2000
39. NOVAK J, VU HL, NOVAK L, et al: Interactions of human mesangial cells with IgA and IgA-containing circulating immune complexes. Kidney Int 62:465-475, 2002
40. CROWLEY-NOWICK PA, CAMPBELL E, SCHROHENLOHER RE, et al: Polyethylene glycol precipitates of serum contain a large proportion of uncomplexed immunoglobulins and C3. Immunol Invest 25:91-101, 1996
41. KERBY JD, VERRAN DJ, LUO KL, et al: Immunolocalization of FGF-1 and receptors in human renal allograft vasculopathy associated with chronic rejection. Transplantation 62:467-475, 1996
42. SCHONERMARK M, DEPPISCH R, RIEDASCH G, et al: Induction of mediator release from human glomerular mesangial cells by the terminal complement components C5b-9. Int Arch Allergy Appl Immunol 96:331-337, 1991
43. LOVETT DH, HAENSCH GM, GOPPELT M, et al: Activation of glomerular mesangial cells by the terminal membrane attack complex of complement. J Immunol 138:2473-2480, 1987
44. COUSER WG, PIPPIN JW, SHANKLAND SJ: Complement (C5b-9) induces DNA synthesis in rat mesangial cells in vitro. Kidney Int 59:905-912, 2001
45. FUJII K, MULLER KD, CLARKSON AR, et al: The effect of IgA immune complexes on the proliferation of cultured human mesangial cells. Am J Kidney Dis 16:207-210, 1990
46. MONTEIRO RC, VAN DE WINKEL JG: IgA Fc receptors. Annu Rev Immunol 21:177-204, 2003
47. DIVEN SC, CAFLISCH CR, HAMMOND DK, et al: IgA induced activation of human mesangial cells: Independent of FcαR1 (CD 89). Kidney Int 54:837-847, 1998
48. WESTERHUIS R, VAN ZANDBERGEN G, VERHAGEN NA, et al: Human mesangial cells in culture and in kidney sections fail to express Fc alpha receptor (CD89). J Am Soc Nephrol 10:770-778, 1999
49. LEUNG JCK, TSANG AWL, CHAN DTM, et al: Absence of CD89, polymeric immunoglobulin receptor, and asialoglycoprotein receptor on human mesangial cells. J Am Soc Nephrol 11:241-249, 2000
50. BARRAT J, GREER MR, PAWLUCZYK IZ, et al: Identification of a novel Fcα receptor expressed by mesangial cells. Kidney Int 57:1936-1948, 2000
51. MOURA IC, CENTELLES MN, ARCOS-FAJARDO M, et al: Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy. J Exp Med 194:417-425, 2001
52. HADDAD E, MOURA IC, ARCOS-FAJARDO M, et al: Enhanced expression of the CD71 mesangial IgA1 receptor in Berger disease and Henoch-Schönlein nephritis: Association between CD71 expression and IgA deposits. J Am Soc Nephrol 14:327-337, 2003
53. SHIBUYA A, SAKAMOTO N, SHIMIZU Y, et al: Fcα/μ receptor mediates endocytosis of IgM-coated microbes. Nature Immunol 1:441-446, 2000
54. MCDONALD KJ, CAMERON AJM, ALLEN JM, et al: Expression of Fc α/μ receptor by human mesangial cells: A candidate receptor for immune complex deposition in IgA nephropathy. Biochem Biophys Res Commun 290:438-442, 2002
55. MOURA IC, ARCOS-FAJARDO M, SADAKA C, et al: Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy. J Am Soc Nephrol 15:622-634, 2004
56. LEUNG JC, TANG SC, CHAN LY, et al: Polymeric IgA increases the synthesis of macrophage migration inhibitory factor by human mesangial cells in IgA nephropathy. Nephrol Dial Transplant 18:36-45, 2003
57. COPPO R, AMORE A: Aberrant glycosylation in IgA nephropathy (IgAN). Kidney Int 65:1544-1547, 2004
58. AMORE A, CIRINA P, CONTI G, et al: Glycosylation of circulating IgA in patients with IgA nephropathy modulates proliferation and apoptosis of mesangial cells. J Am Soc Nephrol 12:1862-1871, 2001
59. JULIAN BA, NOVAK J: IgA nephropathy: An update. Curr Opin Nephrol Hypertens 13:171-179, 2004